Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
Sixth International Conference on Alzheimer’s Disease and Related Disorders: Selected Abstracts

Slide 31

WHITE MATTER LESIONS

1) Long-standing hypertension

2) Hyalinisation of vessel walls

3) Decreased vessel lumen

4) Episodes of hypotension

5) Hypoperfusion/ischemia in vulnerable areas (Deep white matter supplied by long penetrating end-arteries with few collaterals)

6) Demyelination

7) Disconnection of subcortical-cortical association pathways

8) Subcortical dementia


Slide 32

WHITE MATTER LESIONS IN RELATION
TO DEMENTIA IN 85-YEAR-OLDS

   percentage
No dementia 34
Alzheimer's disease 64**
Vascular dementia 70***
Other dementias 80*

Ref. Skoog et al. J Geriatr Psychiatry Neurol 1994


Slide 33

WHITE MATTER LESIONS IN ALZHEIMER'S DISEASE

 Neuropathology
Brun and Englund 1986  60%
CT
Blennow, Wallin et al 1991
Early-onset
Late-onset

25%
76%
Erkinjuntti et al 1987
Before 75
After 75
 
2%
46%


Slide 34

ODDS RATIO FOR DEMENTIA IN RELATION TO
WMLs AND APOEe4 STATUS IN 85-YEAR OLDS

   Odds ratio
WMLs- /ApoEe4- 1.0
WMLs- /ApoEe4+ 1.0
WMLs+ /ApoEe4- 2.2
WMLs+ /ApoEe4+  6.1***

Skoog, Blennow et al
J Neurol Neurosurgy Psychiatr 1998


Slide 35

VASCULAR RISK FACTORS IN ALZHEIMER'S DISEASE

Hypertension
ApoE e4 allele
Generalized atherosclerosis
Coronary heart disease
Changes in cardiac innervation
Atrial fibrillation
Diabetes mellitus
Stroke
Ischemic white matter lesions
Changes in cerebral microvessels

 

Skoog 1997


Slide 36

MICROVASCULAR CHANGES AND ALZHEIMER'S DISEASE

  • Endothelial degeneration
  • Cerebral amyloid angiopathy
  • Loss of the perivascular neural plexus
  • Changes in the capillary wall structure

 


Slide 37

POSSIBLE MECHANISMS FOR THE ASSOCIATION BETWEEN
ALZHEIMER'S DISEASE AND VASCULAR FACTORS

  • Overdiagnosis of Alzheimer's disease in cases of vascular dementia
  • Cerebrovascular disease affects the clinical expression of Alzheimer's disease
  • Shared pathogenesis
  • Vascular disease causes or stimulates Alzheimer's disease
  • Alzheimer's disease causes or stimulates vascular diseases


Slide 38

PROPORTION OF VASCULAR DEMENTIA
USING DIFFERENT CRITERIA

 N = 85 percentage
DSM-IV 76
ICD-10 33
NINDS-AIREN 14
Chui criteria 27

Ref. Wetterling et al Stroke 1996


Slide 39

Click here to view image 39


Slide 40

 

POSSIBLE MECHANISMS FOR THE ASSOCIATION BETWEEN
ALZHEIMER'S DISEASE AND VASCULAR FACTORS

  • Overdiagnosis of Alzheimer's disease in cases of vascular dementia
  • Cerebrovascular disease affects the clinical expression of Alzheimer's disease
  • Shared pathogenesis
  • Vascular disease causes or stimulates Alzheimer's disease
  • Alzheimer's disease causes or stimulates vascular diseases

 


Slide 41

DEMENTIA IN INDIVIDUALS WITH AD
NEUROPATHOLOGY (THE NUN STUDY)

   percentage
No infarcts 57
1-2 lacunar 93
Large infarct 75


Slide 42

 

POSSIBLE MECHANISMS FOR THE ASSOCIATION BETWEEN
ALZHEIMER'S DISEASE AND VASCULAR FACTORS

  • Overdiagnosis of Alzheimer's disease in cases of vascular dementia
  • Cerebrovascular disease affects the clinical expression of Alzheimer's disease
  • Shared pathogenesis
  • Vascular disease causes or stimulates Alzheimer's disease
  • Alzheimer's disease causes or stimulates vascular diseases

 


Slide 43

SHARED PATHOGENIC PATHWAYS
BETWEEN AD AND VASCULAR DISORDER

  • Apolipoprotein e4
  • Oxidative stress
  • Disturbance in the renin-angiotensin system
  • Apoptosis
  • Psychological stress


Slide 44

APOLIPOPROTEIN E (APOE)

Three different alleles (Apo e2, e3, e4)
Three isoforms (ApoE2, E3, E4)
Six different phenotypes

ApoE4 associated with:

Increased Cholesterol
Increased LDL
Coronary heart disease
Atherosclerosis
Alzheimer's disease


Slide 45

SHARED PATHOGENIC PATHWAYS
BETWEEN AD AND VASCULAR DISORDER

  • Apolipoprotein e4
  • Oxidative stress
  • Disturbance in the renin-angiotensin system
  • Apoptosis
  • Psychological stress

 


Slide 46

The Renin-Angiotensin System

Angiotensinogen --(renin)--> Angiotensin I --(Angiotensin I-converting enzyme)--> Angiotensin II

--> Vasoconstriction
Aldosterone secretion
Sodium retention
Sympathetic nervous system
Hyperplasia/hypertrophy in vascular smooth muscle cells


Slide 47

THE RENIN-ANGIOTENSIN SYSTEM IN THE BRAIN

Angiotensinogen --(renin)--> Angiotensin I --(Angiotensin I-converting enzyme)--> Angiotensin II

--> Tonic control over blood pressure
Autoregulation of CBF
Impair memory functions
Other behaviors


Slide 48

ALZHEIMER'S DISEASE

ACE activity in the brain increased
Arregui et al.
J Neurochem 1982
Barnes et al.
Eur J Pharmacol 1991

ACE activity in CSF decreased
Zubenko et al.
Brain Res 1985


Slide 49

SHARED PATHOGENIC PATHWAYS
BETWEEN AD AND VASCULAR DISORDER

  • Apolipoprotein e4
  • Oxidative stress
  • Disturbance in the renin-angiotensin system
  • Apoptosis
  • Psychological stress

 


Slide 50

OXIDATIVE STRESS

Free radical production increased
and/or
Antioxidant defenses decreased


Slide 51

OXIDATIVE STRESS

  • Normal atom
    contains paired electrons
  • Free radical
    contains unpaired electron

    Superoxide
    Hydroxyl
    Nitric oxide
    (endothelial relaxing factor)
    Lipid peroxide
  • Reactive oxygen species
    Oxygen-centered free radicals
    Non-radical oxygen derivates
    - hydrogen peroxide
    - hypochlorous acid

 


Slide 52

DAMAGE TO MOLECULAR TARGETS
BY FREE RADICAL CHAIN REACTIONS

FREE RADICALS (X·) ATTACK NONRADICALS (Y) BY

a) Addition
x· + y --> [x - y]·

b) Electron donation
x· + y --> y·- + x+

c) Electron removal
x + y --> x- + y·+


Slide 53

OXIDATIVE STRESS IN HUMAN DISEASE

Tissue damage (e.g. ischemia) --> Reactive oxygen species increase -->

Free radicals increase --> Damage to proteins, DNA, lipids -->

Cell death


Slide 54

OXIDATIVE STRESS AND FREE RADICALS INVOLVED IN:

  • Atherosclerosis
  • Early hypertension
  • Coronary heart disease
  • Stroke (ischemia)
  • Alzheimer's disease
  • Etc., etc.


Slide 55

OXIDATIVE STRESS

Beta-amyloid -->

Receptor for advanced glycation end products (RAGE)
on neurons, microglia, vascular endothelium -->

Reactive oxygen species -->

Damage neurons
Damage the endothelial lining

Yan et al., Nature 1996


Slide 56

SHARED PATHOGENIC PATHWAYS
BETWEEN AD AND VASCULAR DISORDER

  • Apolipoprotein e4
  • Oxidative stress
  • Disturbance in the renin-angiotensin system
  • Apoptosis
  • Psychological stress


Slide 57

APOPTOSIS

Stimulation -->

Internally encoded suicide program in differentiated cells -->

Apoptosis

          • Changes in the cytoplasm
          • Fragmentation of chromatin
          • Cell membranes preserved


Slide 58

APOPTOSIS

  • Beta-amyloid+
  • Glucocorticoids+
  • Free radicals +
  • Glutamate +
  • Dopamine +
  • Ischemia +
  • Estrogen +


Slide 59

APOPTOSIS IN THE BRAINS OF
SPONTANEOUSLY HYPERTENSIVE RATS

  • Cortex
  • Striatum
  • Hippocampus
  • Thalamus

Hamet et al. Hypertension 1995


Slide 60

SHARED PATHOGENIC PATHWAYS
BETWEEN AD AND VASCULAR DISORDER

  • Apolipoprotein e4
  • Oxidative stress
  • Disturbance in the renin-angiotensin system
  • Apoptosis
  • Psychological stress

 


Slide 61

HYPOTHESIS

Stress

  • Glucocorticoids
  • Immunological factors
  • Hypertension


Slide 62-63

Click here to view image 62
Click here to view image 63


Slide 64

POSSIBLE MECHANISMS FOR THE ASSOCIATION BETWEEN
ALZHEIMER'S DISEASE AND VASCULAR FACTORS

  • Overdiagnosis of Alzheimer's disease in cases of vascular dementia
  • Cerebrovascular disease affects the clinical expression of Alzheimer's disease
  • Shared pathogenesis
  • Vascular disease causes or stimulates Alzheimer's disease
  • Alzheimer's disease causes or stimulates vascular diseases


Slide 65

MICROVASCULAR CHANGES
IN ALZHEIMER'S DISEASE

  • Endothelial degeneration
  • Cerebral amyloid angiopathy
  • Loss of the perivascular neural plexus
  • Changes in the capillary wall structure


<<NOTE: THERE IS A SLIDE MISSING EITHER HERE OR AFTER SLIDE 66; SKOOG HAD BORROWED IT FROM SOMEONE, SO IT WASN'T AVAILABLE TO US>>


Slide 66

Click here to view image 66

BLOOD BARRIER DYSFUNCTION
IN ALZHEIMER'S DISEASE

  • Chronic hypertension
    - increased vascular permeability
    - protein extravasation
    Johannson BB. Dementia 1994
    Nag S. Acta Neuropathol 1984
  • Extravasated plasma proteins in brain
    parenchyma of AD patients
    Eikelenboom et al. Acta Neuropathol (Berlin) 1982
    Licandro et al. Riv Pat Nerv Ment 1983
    Wisniewski et al. Ann NY Acad Sci 1982


Slides 67-69

Click here to view image 67
Click here to view image 68
Click here to view image 69


Slide 70

POSSIBLE MECHANISM BY WHICH
VASCULAR RISK FACTORS MAY CAUSE
ALZHEIMER'S DISEASE

Chronic hypertension, diabetes mellitus -->

Increased vascular permeability -->

Protein extravasation -->

Extravasated plasma proteins -->

Interaction with brain parenchyma -->

"Amyloid cascade"


Slide 71

POSSIBLE MECHANISMS FOR THE ASSOCIATION BETWEEN
ALZHEIMER'S DISEASE AND VASCULAR FACTORS

  • Overdiagnosis of Alzheimer's disease in cases of vascular dementia
  • Cerebrovascular disease affects the clinical expression of Alzheimer's disease
  • Shared pathogenesis
  • Vascular disease causes or stimulates Alzheimer's disease
  • Alzheimer's disease causes or stimulates vascular diseases


Slide 72

VASCULAR FACTORS AND ALZHEIMER'S DISEASE

BETA-AMYLOID INTERACTS WITH ENDOTHELIAL CELLS

I. Produce excess of superoxide radicals

a) scavenge endothelium-derived relaxing factor
> enhanced vasoconstriction

b) produce potent oxidizing agents
> endothelial damage
(lipid peroxidation/other degenerative changes)

II. Pretreatment with superoxide dismutase eliminated the vasoactivity

Thomas et al. (Nature 1996; 380:168-171)


Slide 73

Cerebral amyloid angiopathy -->

Hypertension -->

Cerebral infarctions in
patients with Alzheimer's disease

Olichney et al., Arch Neurol 1995; 52:702-708


Slide 74

CONCLUSION

  • There is an association between Alzheimer's disease and vascular factors
  • The mechanism behind the association is not clear

Possibilities

  • Overdiagnosis of Alzheimer's disease in cases of vascular dementia
  • Cerebrovascular disease affects the clinical expression of Alzheimer's disease
  • Shared pathogenesis
  • Vascular disease causes or stimulates Alzheimer's disease
  • Alzheimer's disease causes or stimulates vascular diseases


Return to Skoog Index


Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad